PT98673A - Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios - Google Patents

Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios

Info

Publication number
PT98673A
PT98673A PT98673A PT9867391A PT98673A PT 98673 A PT98673 A PT 98673A PT 98673 A PT98673 A PT 98673A PT 9867391 A PT9867391 A PT 9867391A PT 98673 A PT98673 A PT 98673A
Authority
PT
Portugal
Prior art keywords
antagonists
intermediaries
platelets
benzimidazole
preparing compounds
Prior art date
Application number
PT98673A
Other languages
English (en)
Other versions
PT98673B (pt
Inventor
Mark Whittaker
Stephen Arthur Bowles
Andrew Miller
Original Assignee
British Bio Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909017878A external-priority patent/GB9017878D0/en
Priority claimed from GB909018040A external-priority patent/GB9018040D0/en
Priority claimed from GB919112214A external-priority patent/GB9112214D0/en
Application filed by British Bio Technology filed Critical British Bio Technology
Publication of PT98673A publication Critical patent/PT98673A/pt
Publication of PT98673B publication Critical patent/PT98673B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98673A 1990-08-15 1991-08-14 Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios PT98673B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909017878A GB9017878D0 (en) 1990-08-15 1990-08-15 Compounds
GB909018040A GB9018040D0 (en) 1990-08-16 1990-08-16 Compounds
GB919112214A GB9112214D0 (en) 1991-06-06 1991-06-06 Compounds

Publications (2)

Publication Number Publication Date
PT98673A true PT98673A (pt) 1992-07-31
PT98673B PT98673B (pt) 1999-01-29

Family

ID=27265233

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98673A PT98673B (pt) 1990-08-15 1991-08-14 Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios

Country Status (18)

Country Link
US (1) US5180723A (pt)
EP (1) EP0543858B1 (pt)
JP (2) JP2976004B2 (pt)
KR (1) KR0185959B1 (pt)
AT (1) ATE198197T1 (pt)
AU (2) AU655595B2 (pt)
CA (1) CA2088761C (pt)
DE (1) DE69132497T2 (pt)
ES (1) ES2153820T3 (pt)
FI (1) FI103409B (pt)
GR (1) GR3035511T3 (pt)
HK (1) HK1012336A1 (pt)
HU (1) HUT67289A (pt)
IE (1) IE70217B1 (pt)
NO (2) NO301228B1 (pt)
NZ (1) NZ239409A (pt)
PT (1) PT98673B (pt)
WO (1) WO1992003423A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
GB9116056D0 (en) * 1991-07-24 1991-09-11 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9201755D0 (en) * 1992-01-28 1992-03-11 British Bio Technology Compounds
GB9202791D0 (en) * 1992-02-11 1992-03-25 British Bio Technology Compounds
DE4206042A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl-substituierte imidazopyridine
DE4327256A1 (de) * 1993-08-13 1995-02-16 Bayer Ag Sulfonylbenzyl-substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
GB2298138B (en) * 1993-11-10 1997-07-09 British Biotech Pharm 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
GB9323162D0 (en) * 1993-11-10 1994-01-05 British Bio Technology 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
AU704972B2 (en) 1994-08-04 1999-05-13 H. Lundbeck A/S Novel benzimidazole derivatives
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
ES2104513B1 (es) * 1995-10-11 1998-07-01 Uriach & Cia Sa J Nuevos derivados del acido 5-aminosalicilico.
ES2155621T3 (es) * 1995-09-08 2001-05-16 Uriach & Cia Sa J Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.
ES2106682B1 (es) * 1995-09-08 1998-07-01 Uriach & Cia Sa J Nuevos derivados azo del acido 5-aminosalicilico.
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US6858630B2 (en) 1999-12-06 2005-02-22 Smithkline Beecham Corporation Naphthimidazole derivatives and their use as thrombopoietin mimetics
WO2001039773A1 (en) * 1999-12-06 2001-06-07 Smithkline Beecham Corporation Thrombopoietin mimetics
ES2165803B1 (es) * 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
EP1435978B1 (en) * 2001-10-17 2014-09-03 Croda, Inc. Esters of aromatic alkoxylated alcohols and fatty carboxylic acids
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
EA200800013A1 (ru) * 2005-06-10 2008-06-30 Эликсир Фармасьютикалз, Инк. Сульфонамидные соединения и их применение
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
EA029443B1 (ru) * 2011-11-23 2018-03-30 Селл Терапи Лимитед Фармацевтическая композиция на основе лизата тромбоцитов
GB201321735D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715600A (pt) * 1966-12-02 1968-06-04
US4612323A (en) * 1983-06-27 1986-09-16 Sumitomo Chemical Company, Limited Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole
US4804658A (en) * 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
US4914108A (en) * 1988-03-14 1990-04-03 G. D. Searle & Co. 5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity
ATE118006T1 (de) * 1988-03-15 1995-02-15 Searle & Co 1h/3h-(4-(n,n-cycloalkyl und/oder verzweigtes alkylcarboxamido)-benzyl>imdazo(4,5-c>pyridine als paf-antagonisten.
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5157026A (en) * 1989-05-30 1992-10-20 Merck & Co., Inc. Oxo-purines as angiotensin II antagonists
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides

Also Published As

Publication number Publication date
ES2153820T3 (es) 2001-03-16
CA2088761A1 (en) 1992-02-16
US5180723A (en) 1993-01-19
FI930634A0 (fi) 1993-02-12
HK1012336A1 (en) 1999-07-30
DE69132497T2 (de) 2001-06-13
AU658337B2 (en) 1995-04-06
EP0543858A1 (en) 1993-06-02
JPH11315070A (ja) 1999-11-16
IE70217B1 (en) 1996-10-30
FI103409B1 (fi) 1999-06-30
WO1992003423A1 (en) 1992-03-05
KR0185959B1 (en) 1999-05-01
AU8426891A (en) 1992-03-17
NO972615D0 (no) 1997-06-06
NO301228B1 (no) 1997-09-29
DE69132497D1 (de) 2001-01-25
GR3035511T3 (en) 2001-06-29
PT98673B (pt) 1999-01-29
JP2976004B2 (ja) 1999-11-10
JPH06500316A (ja) 1994-01-13
EP0543858B1 (en) 2000-12-20
HU9300389D0 (en) 1993-04-28
AU655595B2 (en) 1995-01-05
KR930701413A (ko) 1993-06-11
ATE198197T1 (de) 2001-01-15
FI103409B (fi) 1999-06-30
AU5309094A (en) 1994-03-17
NO930498L (no) 1993-04-14
IE912875A1 (en) 1992-02-26
FI930634A (fi) 1993-04-05
NO930498D0 (no) 1993-02-12
NO972615L (no) 1997-06-06
CA2088761C (en) 1999-11-16
NZ239409A (en) 1994-05-26
HUT67289A (en) 1995-03-28
JP3120075B2 (ja) 2000-12-25

Similar Documents

Publication Publication Date Title
PT98673A (pt) Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios
PT98674A (pt) Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios
PT937048E (pt) Derivados heterociclicos que inibem factor xa
DK0530505T3 (da) Hydantoinderivater
PH22520A (en) Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them
KR960007565A (ko) 약제로서의 치환된 4-페닐-6-아미노-니코틴산 유도체의 용도
MX162894B (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
ES2040366T3 (es) Procedimiento de preparacion de nuevos derivados de 1-(bencilpiperidino)2-propanol.
AU580963B2 (en) New compounds derived from diphenyl-methylene-ethylamine
RO93482A (ro) Derivati 1-substituiti ai acidului 6-fluor-7-(pirol-1-il)-1,4-dihidro-4-oxochinolin-3-carboxilic
ES537389A0 (es) Un procedimiento para la preparacion de un derivado de acido 2-anilino-1, 6-dihidro-6-oxo-5-pirimidincarboxilico
PT95743A (pt) /processo para a preparacao de derivados da-benzo{b//1,8/ naftiridina e de composicoes farmaceuticas que os contem
NO902148L (no) Fremgangsmaate til fremstilling av sterkt vannopploeselige,stabile, krystallinske salter av 2',3'-dideoksyinosinmonohydrat, 2',3'-dideoksy-2',3'-didehydrotymidinmonohydrat og2',3'-dideoksy-2'-fluorinosinhemihydrat.
PT89236A (pt) Processo para a preparacao de compostos beta-lactamicos
ES2143453T3 (es) Uso de derivados de dihidropiridina para la profilaxis o el tratamiento de trastornos de la circulacion cerebral.
PT84760B (pt) Processo de preparacao de derivados de tiadiazinona, de seus intermediarios e de composicoes farmaceuticas

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920318

FG3A Patent granted, date of granting

Effective date: 19981022

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040430

NF3A Restitutio in integrum

Free format text: RESTITUTIO IN INTEGRUM

Effective date: 19910814

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080422